| Identification | Back Directory | [Name]
2H-1-Benzazepin-2-one, 7-[2-[(1,6-dihydro-6-oxo-4-propyl-2-pyrimidinyl)thio]acetyl]-1,3,4,5-tetrahydro- | [CAS]
1223194-71-5 | [Synonyms]
2H-1-Benzazepin-2-one, 7-[2-[(1,6-dihydro-6-oxo-4-propyl-2-pyrimidinyl)thio]acetyl]-1,3,4,5-tetrahydro- | [Molecular Formula]
C19H21N3O3S | [MOL File]
1223194-71-5.mol | [Molecular Weight]
371.45 |
| Hazard Information | Back Directory | [Description]
S07-2010 is an AKR1C3 inhibitor. S07-2010 may serve as promising therapeutic adjuvants toward new therapeutics for countering drug resistance. | [Uses]
S07-2010 is a potent pan-AKR1C (aldo-keto reductase family 1 member C) inhibitor, with IC50 values of 0.19, 0.36, 0.47, and 0.73 μM for AKR1C3, AKR1C4, AKR1C1 and AKR1C2, respectively. S07-2010 induces apoptosis in A549/DDP cells. S07-2010 strengthens the cytotoxicity of chemotherapeutic agents in drug-resistant cells. S07-2010 significantly inhibits the proliferation of drug-resistant cells[1]. | [References]
[1] Siyu He, et al. Discovery of Novel Aldo-Keto Reductase 1C3 Inhibitors as Chemotherapeutic Potentiators for Cancer Drug Resistance. ACS Med. Chem. Lett. 2022. |
|
|